AU9103782A - Amoxycillin trihydrate and potassium clavulanate extrudable composition - Google Patents

Amoxycillin trihydrate and potassium clavulanate extrudable composition

Info

Publication number
AU9103782A
AU9103782A AU91037/82A AU9103782A AU9103782A AU 9103782 A AU9103782 A AU 9103782A AU 91037/82 A AU91037/82 A AU 91037/82A AU 9103782 A AU9103782 A AU 9103782A AU 9103782 A AU9103782 A AU 9103782A
Authority
AU
Australia
Prior art keywords
potassium clavulanate
extrudable composition
amoxycillin trihydrate
amoxycillin
trihydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU91037/82A
Other languages
English (en)
Inventor
Barry William Burnstead
Francis Walter Grimmett
Michael William Hartnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of AU9103782A publication Critical patent/AU9103782A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU91037/82A 1981-12-02 1982-12-01 Amoxycillin trihydrate and potassium clavulanate extrudable composition Abandoned AU9103782A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8136295 1981-12-02
GB8136295 1981-12-02

Publications (1)

Publication Number Publication Date
AU9103782A true AU9103782A (en) 1983-06-09

Family

ID=10526317

Family Applications (1)

Application Number Title Priority Date Filing Date
AU91037/82A Abandoned AU9103782A (en) 1981-12-02 1982-12-01 Amoxycillin trihydrate and potassium clavulanate extrudable composition

Country Status (9)

Country Link
EP (1) EP0080862B1 (cg-RX-API-DMAC7.html)
JP (1) JPS58109419A (cg-RX-API-DMAC7.html)
AU (1) AU9103782A (cg-RX-API-DMAC7.html)
DE (1) DE3266580D1 (cg-RX-API-DMAC7.html)
ES (1) ES517868A0 (cg-RX-API-DMAC7.html)
HK (1) HK25086A (cg-RX-API-DMAC7.html)
MY (1) MY8600479A (cg-RX-API-DMAC7.html)
NZ (1) NZ202657A (cg-RX-API-DMAC7.html)
ZA (1) ZA828797B (cg-RX-API-DMAC7.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61210025A (ja) * 1985-03-14 1986-09-18 Teisan Seiyaku Kk 安定化された抗生物質複合顆粒製剤
FR2594334B1 (fr) * 1986-02-20 1990-01-12 Bristol Myers Co Composition pharmaceutique injectable a base d'amoxicilline
US5750685A (en) * 1987-01-29 1998-05-12 Smithkline Beecham, P.L.C. Process for preparing potassium clavulanate in rossette form
DK175709B1 (da) * 1987-01-29 2005-01-31 Beecham Group Plc Fremgangsmåde til fremstilling af kalium-clavulanat
US5288861A (en) * 1987-01-29 1994-02-22 Beecham Group Plc Potassium clavulanate in rosette form
EP0281200B1 (en) * 1987-03-02 1994-01-19 Yamanouchi Europe B.V. Pharmaceutical composition, pharmaceutical granulate and process for their preparation
US5211958A (en) * 1987-11-30 1993-05-18 Gist-Brocades, N.V. Pharmaceutical composition and process for its preparation
DE68916983T2 (de) * 1988-02-25 1995-01-19 Yamanouchi Europ Bv Verfahren zur Herstellung eines pharmazeutischen Granulats.
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
GB9007945D0 (en) * 1990-04-07 1990-06-06 Beecham Group Plc Pharmaceutical formulation
US5670170A (en) * 1990-04-27 1997-09-23 Beecham Group P.L.C. Pharamaceutical formulation
RU2096955C1 (ru) * 1991-03-01 1997-11-27 Е.И.Дюпон Де Немур Энд Компани Вододиспергируемая гранулированная пестицидная композиция, получаемая методом экструзии, и способ ее получения
GB9114950D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
SI9200139A (en) * 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
DZ2028A1 (fr) 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
JP3501289B2 (ja) * 1995-09-07 2004-03-02 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 医薬処方
IL125214A0 (en) * 1996-02-29 1999-03-12 Fujisawa Pharmaceutical Co Beta-lactam antibiotic-containing tablet and method for producing the same
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
TW474824B (en) 1996-09-13 2002-02-01 Basf Ag The production of solid pharmaceutical forms
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
WO2001000177A1 (en) * 1999-06-29 2001-01-04 Micio Pharma Chemical Aktiengesellschaft Retard formulation of amoxicillin for oral administration
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
AT413983B (de) * 2001-04-12 2006-08-15 Sandoz Ag K-clavulanat in der form eines granulates
AT412344B (de) * 2001-04-12 2005-01-25 Sandoz Ag Hydrophobisierte teilchen von k-clavulanat
EP1581191A1 (en) * 2002-11-26 2005-10-05 LEK Pharmaceuticals D.D. Pharmaceutical compositions comprising amoxicillin and clavulanic acid
US8715734B2 (en) 2004-02-24 2014-05-06 Sandoz Ag Amoxicilline instant granulate
WO2005115347A1 (en) * 2004-05-31 2005-12-08 Sam-A Pharmaceuticals Co., Ltd. Dispersible tablet comprising beta lactam antibiotics and process for preparing the same
KR100638315B1 (ko) * 2004-07-23 2006-10-25 주식회사 대웅제약 다중 필름 코팅된 코어층을 갖는 클라불라네이트 및아목시실린-함유 유핵정
HK1214519A1 (zh) 2013-03-15 2016-07-29 Braintree Laboratories, Inc. 雙用途硫酸鹽口服藥物組合物片劑及其使用方法
JP2025153047A (ja) 2024-03-29 2025-10-10 サーモス株式会社 調理器用蓋

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1532993A (en) * 1975-03-07 1978-11-22 Beecham Group Ltd Injectable antibiotic compositions
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
IL58461A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a clavulanic acid salt
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate

Also Published As

Publication number Publication date
MY8600479A (en) 1986-12-31
ES8401851A1 (es) 1984-01-01
ES517868A0 (es) 1984-01-01
JPS58109419A (ja) 1983-06-29
NZ202657A (en) 1985-05-31
HK25086A (en) 1986-04-11
JPH026332B2 (cg-RX-API-DMAC7.html) 1990-02-08
DE3266580D1 (en) 1985-10-31
ZA828797B (en) 1983-09-28
EP0080862A1 (en) 1983-06-08
EP0080862B1 (en) 1985-09-25

Similar Documents

Publication Publication Date Title
AU9103782A (en) Amoxycillin trihydrate and potassium clavulanate extrudable composition
AU8605382A (en) Penicillins and azetidinones
AU552403B2 (en) Anthelmintic composition and use
NZ198241A (en) Tablet containing amoxycillin and potassium clavulanate
AU547552B2 (en) 6-alkylidene penem derivatives
AU568062B2 (en) B-lactam antibiotic
AU7271981A (en) Beta-lactam antibiotics
AU8091182A (en) Cephalosporin
AU8011582A (en) Carbapenem antibiotics
AU8891882A (en) Dioximino cephalosporin
AU548964B2 (en) Friction-actuated extrusion
AU3805885A (en) 6-alkylidene penem derivatives
AU562008B2 (en) Antibacterial penem derivatives
AU4338179A (en) Pencillins and cephalosporins
AU548837B2 (en) Stabilised polyolefin composition
AU548337B2 (en) Dentifrice composition
AU530789B2 (en) Amoxycillin composition
AU8011782A (en) Carbapenem antibiotics
AU8113282A (en) Beta-lactam antibiotics
AU4371285A (en) Film extrusion
AU549784B2 (en) Lyophilised penicillins
AU8012282A (en) Carbapenem antibiotics
AU549271B2 (en) Levamisole composition
AU8400282A (en) Beta-lactam derivatives
AU535187B2 (en) Prochloraz and guazatine as fungacide